Explore another way you may receive treatment.

Potential OPDIVO® (nivolumab) user dancing with his wife in the living room.
Potential OPDIVO® (nivolumab) user dancing with his wife in the living room.

Your fight against advanced
kidney cancer
may start or continue here

OPDIVO is an FDA-approved immunotherapy that is the foundation for three different uses in advanced kidney cancer, or renal cell carcinoma (RCC)

Actor portrayals.

Advanced kidney cancer

OPDIVO + YERVOY is a treatment option for certain adults with previously untreated kidney cancer that has spread (advanced RCC)

Advanced kidney cancer that may benefit from targeted therapy

OPDIVO, in combination with CABOMETYX® (cabozantinib), is a treatment option for certain adults with previously untreated kidney cancer that has spread (advanced RCC)

Previously treated kidney cancer

OPDIVO is a treatment option for certain adults with kidney cancer (RCC) when your cancer has spread or grown after treatment with other cancer medications

See treatment plans and what to expect from an OPDIVO® IV infusion or OPDIVO® QVANTIG™ subcutaneous injection.
Explore another way you may receive treatment

You and your healthcare provider may have a choice between under-the-skin injections (subcutaneous injection) with OPDIVO Qvantig and intravenous (lV) infusions with OPDIVO

OPDIVO Qvantig cannot be used in combination with YERVOY. OPDIVO, OPDIVO-based combination treatments, OPDIVO Qvantig, and OPDIVO Qvantig-based combination treatments will not work for everyone. Individual results may vary.

Man exploring real patients stories of experiences with OPDIVO® (nivolumab) or other OPDIVO-based combinations.

Patient stories

Real patients share their experiences with OPDIVO and OPDIVO-based treatments

Frequently asked questions about treatment with OPDIVO® (nivolumab).

Have questions about treatment?

We have answers about getting treatment, monitoring, and more

Hands exploring cost information and financial help for OPDIVO® (nivolumab).

Cost information and financial help

Find information about cost and access to OPDIVO



466-US-2500012   04/25